Press Releases

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Five Prime Therapeutics, Inc. (Nasdaq: FPRX), a biotechnology company discovering and developing innovative i

NEW YORK--(BUSINESS WIRE)-- NIKE, Inc. (NYSE: NKE) opens its newest Nike House of Innovation, on Thurs., Nov.15 as Nike NYC: a 68,000 sq. ft., six-level, cross-category premium Nike store located at 650 Fifth Ave. Nike NYC is the pinnacle expression of modern retail, representing the best of Nike global product, experiences and sport innovation. This press release features multimedia. Vi

IRVINE, Calif.--(BUSINESS WIRE)-- The Patient Safety Movement is pleased to award UCI Health with the Foundation’s first-ever Five-Star Hospital ranking, to an academic medical center. UCI Health was recognized for implementing 29 evidence-based Actionable Patient Safety Solutions (APSS) – processes designed to help hospitals eliminate the leading causes of preventable patient deaths in hospitals. I

PLEASANTON, Calif.--(BUSINESS WIRE)-- An increasing number of data, technology, and service providers are partnering with Veeva Systems (NYSE:VEEV) to empower life sciences organ

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2018 fiscal year (FY18) and fourth quarter (4Q18) ended August 31, 2018. Results for the 2018 fiscal year (FY18): Revenues were $29.7 million, up 22.9

HOUSTON--(BUSINESS WIRE)-- SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using its universal donor product, CybroCell™, today announced that a single injection of modified human dermal fibroblasts (HDFs), resulted in significant improvements of disc height and pain reduction 12 months after injection of the cell therapy for patients with degene

NESS ZIONA, Israel--(BUSINESS WIRE)-- Foresight Autonomous Holdings Ltd., an innovator in automotive vision systems (Nasdaq and TASE: FRSX), today reported financial results for the third quarter ended September 30, 2018. Foresight ended the third quarter of 2018 with $19.3 million in cash and short-term deposits, GAAP net loss of $3.75 million and non-GAAP net loss for the same period of $3.76 million.

DEERFIELD, Ill.--(BUSINESS WIRE)-- Fortune Brands Home & Security, Inc., an industry-leading home and security products company, today announced it has partnered with City Colleges of Chicago to create a new Skilled Trades Scholarship. The first group of 14 recipients are pursuing degrees or certificates across Construction Management and Carpentry, Plumbing and HVAC. The scholarship aims to crea

SAN FRANCISCO--(BUSINESS WIRE)-- The Golden State Warriors, Chase Center and RingCentral, Inc. (NYSE:RNG), a leading provider of global enterprise cloud communications an

CRANBURY, N.J.--(BUSINESS WIRE)-- Physicians’ Education Resource® (PER®), the nation’s leading resource for oncology and hematology continuing medical education (CME), honored Robert Figlin, M.D., FACP, as this year’s Educator of the Year. The award ceremony took place Thursday, Nov. 8, at the 36th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow meeting

EMERYVILLE, Calif.--(BUSINESS WIRE)-- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commerciali

LAS VEGAS--(BUSINESS WIRE)-- The integral roles of technology, teamwork and training in driving a manufacturer’s success were key themes of the keynote presentations at the IQMS Pinnacle User Conference. The discussions were part of the broader

SACRAMENTO, Calif.--(BUSINESS WIRE)-- Aaron Blum, Co-Founder, COO and Chief Compliance Officer of ERI, the largest fully integrated IT and electronics asset disposition provider and cybersecu

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- HeartFlow, Inc. today announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the recommendation by the C

PARIS--(BUSINESS WIRE)-- Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the European Commission (EC) has approved Cabometyx® (cabozantinib) 20, 40, 60 mg as a monotherapy for hepatocellular carcinoma (HCC) in adults who have previously been treated with sorafenib. This approval allows for the marketing of Cabometyx® (cabozantinib) in this